Skip to main content Skip to main navigation menu Skip to site footer

The effect of turmeric extract (Curcuma longa) on IL-6 expression

  • Yohannes Sugiarto ,
  • Selamat Budijitno ,

Abstract

Background: Breast cancer in Indonesia is reported to have reached 68,858 out of 396,914 new cases of cancer, with an incidence rate of 16.6% based on Globocan 2020 data. Complementary therapies are much sought after for psychological and economic reasons and have minimal side effects. Curcumin has anti-carcinogenic properties. IL-6 plays an important role in the growth and metastasis of breast cancer cells, renewal of breast cancer stem cells, and drug resistance in breast cancer stem cells.

Methods: A randomized controlled trial with post-test only group design using artificial female Balb/c strain rats (Mus Musculus) with DMBA-induced mammary adenocarcinoma nodules were reported, rats were divided into four groups randomly, namely, Control (K), Treatment 1: turmeric extract dose 100mg/KgBW (P1), Treatment 2: turmeric extract dose 150mg/KgBW (P2), Treatment 3: turmeric extract dose 200mg/KgBW (P3). Variables under study were IL-6 expression. One Way Anova test, followed by the Post-hoc Test, was used to test  the difference among and between groups.

Results: The mean value of IL-6 expression in groups K (53,59 ± 8,37), P1 (50,66 ± 9,59), P2 (66,93 ± 9,64), P3 (64,58 ± 5,97). The Post-Hoc test showed significant differences in IL-6 expression from group K against P2 (p=0.038), group P1 against P2 (p=0.015), and P3 (p=0.040).

Conclusion: Turmeric extract (Curcuma longa) had an effect on IL-6 expression in the control group and the treatment group.

References

  1. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer: Targets and Therapy. 2019 Apr;Volume 11:151–64.
  2. Bhattacharyya GS, Doval DC, Desai CJ, Chaturvedi H, Sharma S, Somashekhar SP. Overview of Breast Cancer and Implications of Overtreatment of Early-Stage Breast Cancer: An Indian Perspective. JCO Glob Oncol. 2020 Nov;(6):789–98.
  3. World Health Organization. Breast Cancer. WHO. 2021.
  4. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May 4;71(3):209–49.
  5. Komisi Penanggulangan Kanker Nasional. Panduan Nasional Penanganan Kanker Payudara. Indonesia; 2015.
  6. Jermini M, Dubois J, Rodondi PY, Zaman K, Buclin T, Csajka C, et al. Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre. Sci Rep. 2019 Mar 25;9(1):5078.
  7. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers. 2019 Sep 23;5(1):66.
  8. Bevers TB, Helvie M, Bonaccio E, Calhoun KE, Daly MB, Farrar WB, et al. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018 Nov 15;16(11):1362–89.
  9. Priyadarsini KI. The Chemistry of Curcumin: From Extraction to Therapeutic Agent. Molecules [Internet]. 2014 Dec 1 [cited 2024 Mar 17];19(12):20091. Available from: /pmc/articles/PMC6270789/
  10. Mansouri K, Rasoulpoor S, Daneshkhah A, Abolfathi S, Salari N, Mohammadi M, et al. Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer [Internet]. 2020 Aug 24 [cited 2024 Mar 17];20(1). Available from: https://pubmed.ncbi.nlm.nih.gov/32838749/
  11. Hardanto GR, Budijitno S, Hardian H. Effect of Artemisia vulgaris Extract on Granzyme Expression and Tumor Mass Diameter (Study of Adriamycin Cyclophosphamide Chemotherapy in Adenocarcinoma Mammae C3H Mice Model). Jurnal Kedokteran Brawijaya. 2021 Aug 31;31(4):205–10.
  12. Farghadani R, Naidu R. Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer. Cancers (Basel). 2021 Jul 8;13(14):3427.
  13. Jalilian E, Abolhasani-Zadeh F, Afgar A, Samoudi A, Zeinalynezhad H, Langroudi L. Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by Curcumin in breast cancer therapy. Sci Rep. 2023 Nov 26;13(1):20770.
  14. Yadav R, Jee B, Awasthi SK. Curcumin Suppresses the Production of Pro-inflammatory Cytokine Interleukin-18 in Lipopolysaccharide Stimulated Murine Macrophage-Like Cells. Indian Journal of Clinical Biochemistry. 2015 Jan 15;30(1):109–12.
  15. Ghandadi M, Sahebkar A. Curcumin: An Effective Inhibitor of Interleukin-6. Curr Pharm Des. 2017 Mar 27;23(6):921–31.
  16. Mills PJ, Ancoli-Israel S, Parker B, Natarajan L, Hong S, Jain S, et al. Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer. Brain Behav Immun. 2008 Jan 1;22(1):98–104.
  17. Girard BM, Cheppudira BP, Malley SE, Schutz KC, May V, Vizzard MA. Increased expression of interleukin-6 family members and receptors in urinary bladder with cyclophosphamide-induced bladder inflammation in female rats. Front Neurosci. 2011 Feb 22;5(FEB):8728.
  18. Gorabi AM, Razi B, Aslani S, Abbasifard M, Imani D, Sathyapalan T, et al. Effect of curcumin on proinflammatory cytokines: A meta-analysis of randomized controlled trials. Cytokine. 2021 Jul;143:155541.
  19. Manore SG, Doheny DL, Wong GL, Lo HW. IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment. Front Oncol. 2022 Mar 15;12:866014.

How to Cite

Sugiarto, Y., & Budijitno, S. (2024). The effect of turmeric extract (Curcuma longa) on IL-6 expression. Intisari Sains Medis, 15(1), 402–407. https://doi.org/10.15562/ism.v15i1.1967

HTML
0

Total
0

Share

Search Panel

Yohannes Sugiarto
Google Scholar
Pubmed
ISM Journal


Selamat Budijitno
Google Scholar
Pubmed
ISM Journal